Jan Philipp Bewersdorf1, Uwe Koedel1, Maximilian Patzig2, Konstantinos Dimitriadis1, Grit Paerschke1, Hans-Walter Pfister1, Matthias Klein3. 1. Department of Neurology, Klinikum der Ludwig-Maximilians-University (LMU) Munich, Marchioninistr. 15, 81377, Munich, Germany. 2. Department of Neuroradiology, Klinikum der Ludwig-Maximilians-University (LMU) Munich, Marchioninistr. 15, 81377, Munich, Germany. 3. Department of Neurology, Klinikum der Ludwig-Maximilians-University (LMU) Munich, Marchioninistr. 15, 81377, Munich, Germany. matthias.klein@med.uni-muenchen.de.
Abstract
PURPOSE: Herpes simplex virus (HSV) encephalitis continues to be the most common form of sporadic lethal encephalitis worldwide. The wide spectrum of clinical presentations and laboratory findings often poses a diagnostic challenge for physicians which might delay administration of life-saving therapy with acyclovir. Atypical presentations of HSV encephalitis have become increasingly prevalent with better diagnostic techniques and have not been well studied. METHODS: We retrospectively evaluated all consecutive PCR-proven HSV encephalitis cases treated at the Hospital of the Ludwig-Maximilians-University in Munich, Germany from January 1, 2013 to February 28, 2018. RESULTS: We included 18 patients with PCR-proven HSV encephalitis. The most common clinical features were altered mental status (77.8%), focal neurologic deficits (72.2%) and fever (72.2%). Remarkably, four of these patients (22.2%) had a normocellular cerebrospinal fluid (CSF) on admission. Electroencephalography and magnetic resonance imaging abnormalities were highly sensitive for HSV encephalitis independent of CSF cell count. Striking atypical findings on MRI were extensive global brain swelling and severe brainstem involvement in single patients. Of note, initial CT scans were normal in 11 out of 16 patients (68.8%). All patients were treated with acyclovir. Three patients still developed a clinical deterioration under therapy with acyclovir with one patient requiring decompressive craniotomy due to bilateral space-occupying temporal lobe hemorrhage. 94.4% of the patients survived but only 38.9% were discharged with a good clinical outcome (Glasgow Outcome Score = 5). CONCLUSION: Atypical presentations of HSV encephalitis seem to be more common than previously thought and physicians should apply a high level of clinical suspicion and a low threshold to initiate life-saving acyclovir therapy in suspected cases.
PURPOSE: Herpes simplex virus (HSV) encephalitis continues to be the most common form of sporadic lethal encephalitis worldwide. The wide spectrum of clinical presentations and laboratory findings often poses a diagnostic challenge for physicians which might delay administration of life-saving therapy with acyclovir. Atypical presentations of HSV encephalitis have become increasingly prevalent with better diagnostic techniques and have not been well studied. METHODS: We retrospectively evaluated all consecutive PCR-proven HSV encephalitis cases treated at the Hospital of the Ludwig-Maximilians-University in Munich, Germany from January 1, 2013 to February 28, 2018. RESULTS: We included 18 patients with PCR-proven HSV encephalitis. The most common clinical features were altered mental status (77.8%), focal neurologic deficits (72.2%) and fever (72.2%). Remarkably, four of these patients (22.2%) had a normocellular cerebrospinal fluid (CSF) on admission. Electroencephalography and magnetic resonance imaging abnormalities were highly sensitive for HSV encephalitis independent of CSF cell count. Striking atypical findings on MRI were extensive global brain swelling and severe brainstem involvement in single patients. Of note, initial CT scans were normal in 11 out of 16 patients (68.8%). All patients were treated with acyclovir. Three patients still developed a clinical deterioration under therapy with acyclovir with one patient requiring decompressive craniotomy due to bilateral space-occupying temporal lobe hemorrhage. 94.4% of the patients survived but only 38.9% were discharged with a good clinical outcome (Glasgow Outcome Score = 5). CONCLUSION: Atypical presentations of HSV encephalitis seem to be more common than previously thought and physicians should apply a high level of clinical suspicion and a low threshold to initiate life-saving acyclovir therapy in suspected cases.
Authors: X Escobar-Pérez; A J Dorta-Contreras; M T Interián-Morales; E Noris-García; M Ferrá-Valdés Journal: Arq Neuropsiquiatr Date: 2000-03 Impact factor: 1.420
Authors: Aida Rodríguez-Sainz; Inés Escalza-Cortina; Laura Guio-Carrión; Alexandra Matute-Nieves; Marian Gómez-Beldarrain; Guillermo Carbayo-Lozano; Juan Carlos Garcia-Monco Journal: Clin Neurol Neurosurg Date: 2013-07-23 Impact factor: 1.876
Authors: Julia Granerod; Helen E Ambrose; Nicholas Ws Davies; Jonathan P Clewley; Amanda L Walsh; Dilys Morgan; Richard Cunningham; Mark Zuckerman; Ken J Mutton; Tom Solomon; Katherine N Ward; Michael Pt Lunn; Sarosh R Irani; Angela Vincent; David Wg Brown; Natasha S Crowcroft Journal: Lancet Infect Dis Date: 2010-10-15 Impact factor: 25.071
Authors: C L Gordon; P D R Johnson; M Permezel; N E Holmes; G Gutteridge; C F McDonald; D P Eisen; A J Stewardson; J Edington; P G P Charles; N Crinis; M J Black; J Torresi; M L Grayson Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: A Venkatesan; A R Tunkel; K C Bloch; A S Lauring; J Sejvar; A Bitnun; J-P Stahl; A Mailles; M Drebot; C E Rupprecht; J Yoder; J R Cope; M R Wilson; R J Whitley; J Sullivan; J Granerod; C Jones; K Eastwood; K N Ward; D N Durrheim; M V Solbrig; L Guo-Dong; C A Glaser Journal: Clin Infect Dis Date: 2013-07-15 Impact factor: 9.079
Authors: Jonathan D Krett; J David Beckham; Kenneth L Tyler; Amanda L Piquet; Lakshmi Chauhan; Carla J Wallace; Daniel M Pastula; Ronak K Kapadia Journal: Neurohospitalist Date: 2022-05-27
Authors: Carlen A Yuen; James Mastrianni; Saad Ali; Peter Pytel; Deric M Park; Kourosh Rezania Journal: Medicine (Baltimore) Date: 2020-09-18 Impact factor: 1.817